Latest Global Pharma News News
Amneal Pharmaceuticals Awarded a Sub-License from MPP to Manufacture and Commercialize Generic Version of Co-Packaged Nirmatrelvir and Ritonavir.
Amneal Pharmaceuticals announced it has been awarded a…
Lupin gets USFDA approval for Sildenafil Oral Suspension, 10mg/mL.
Global pharma major Lupin Limited (Lupin) announced that…
Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg.
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final…
Lupin Enters into Licensing Agreement with Alvion to market Cardiometabolic Drugs in the Southeast Asia region
Lupin Enters into Licensing Agreement with Alvion to market Cardiometabolic Drugs in the Southeast Asiaregion Global pharma major, Lupin Limited (Lupin) announced…
US Food and Drug Administration has decided to conduct surprise inspections of drug manufacturing facilities outside the US, including units in India
US Food and Drug Administration has decided to…
Lupin gets U.S. FDA approval for Vigabatrin for Oral Solution USP.
Lupin Limited (Lupin) on March 11, 2022 announced…
NATCO Pharma Announced to Launch the First Generic Version of Revlimid® (Lenalidomide capsules), in the U.S. market.
NATCO Pharma Limited announces launch of the first…
Amneal Pharmaceutical receives USFDA approval for RELEUKO™ (filgrastim-ayow), a biosimilar referencing Neupogen.
Amneal Pharmaceutical receives USFDA approval for RELEUKO™ (filgrastim-ayow),…
Lupin Launches Sevelamer Hydrochloride Tablets in the United States
Global pharma major Lupin Limited (Lupin) announced the…
Zydus group announced its new brand identity- Cadila Healthcare to be known as Zydus Lifesciences.
The Zydus group announced its new brand identity…
